Pharvaris N.V.
PHVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001830487
In the last 90 days, Pharvaris N.V. insiders filed 0 open-market purchases and 18 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $2.23B in total; Viking Global Investors is the only superinvestor holding it.
Q2 2025 vs. Q1 2025
How the institutions holding Pharvaris N.V. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 52 | 60 | +8 |
| Shares | 44.9M | 45.0M | +101.1K (+0.2%) |
| Value | $705.5M | $792.7M | +$87.2M (+12.4%) |
New holders (9)
Institutions that held Pharvaris N.V. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 1,062,911 | $18.7M | 0.80% |
| ADAR1 Capital Management, LLC | 34,124 | $600.6K | 0.10% |
| Citadel Advisors LLC | 29,221 | $514.3K | 0.00% |
| Boothbay Fund Management, LLC | 16,187 | $284.9K | 0.01% |
| Millennium Management LLC | 13,285 | $233.8K | 0.00% |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 3,261 | $57.0K | 0.00% |
| Point72 Asia (Singapore) Pte. Ltd. | 369 | $6.49K | 0.00% |
| Centerpoint Advisors, LLC | 100 | $2.00K | 0.00% |
| Royal Bank of Canada | 58 | $1.00K | 0.00% |
Sold out (1)
Institutions that held Pharvaris N.V. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Vanguard Group Inc | 12,740 | $200.0K |